David Kelley
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes, Prenatal Substance Exposure Effects, Maternal Mental Health During Pregnancy and Postpartum, Healthcare Policy and Management
Most-Cited Works
- → Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance(2009)387 cited
- → Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM(1990)309 cited
- → Association between trajectories of buprenorphine treatment and emergency department and in‐patient utilization(2015)127 cited
- → Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018(2021)111 cited
- → Outcomes associated with the use of medications for opioid use disorder during pregnancy(2021)106 cited
- → Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder(2019)96 cited
- → Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program(2015)72 cited
- → Confidence of graduating internal medicine residents to perform ambulatory procedures(2000)68 cited
- → The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder(2019)64 cited
- → Medicaid Admissions And Readmissions: Understanding The Prevalence, Payment, And Most Common Diagnoses(2014)60 cited